{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T14:06:09Z","timestamp":1720793169397},"reference-count":37,"publisher":"Media Sphere Publishing House","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. nevrol. psikhiatr. im. S.S. Korsakova"],"published-print":{"date-parts":[[2017]]},"DOI":"10.17116\/jnevro20171179263-69","type":"journal-article","created":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T04:39:41Z","timestamp":1512621581000},"page":"63","source":"Crossref","is-referenced-by-count":1,"special_numbering":"Vyp. 2","title":["Perampanel in the treatment of patients with epilepsy"],"prefix":"10.17116","volume":"117","author":[{"given":"F. K.","family":"Rider","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6743","reference":[{"key":"key-10.17116\/jnevro20171179263-69-1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2016.08.007"},{"key":"key-10.17116\/jnevro20171179263-69-2","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0b013e3182563b19"},{"key":"key-10.17116\/jnevro20171179263-69-3","unstructured":"Davydova ON, Boldyrev AA. Glutamate receptors in cells of the nervous and immune systems. Annaly klinicheskoi i eksperimental\u2019noi nevrologii. 2007;4:28-34. (In Russ.)"},{"key":"key-10.17116\/jnevro20171179263-69-4","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12099"},{"key":"key-10.17116\/jnevro20171179263-69-5","doi-asserted-by":"publisher","DOI":"10.1016\/j.nurt.2006.11.010"},{"key":"key-10.17116\/jnevro20171179263-69-6","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2016.09.028"},{"key":"key-10.17116\/jnevro20171179263-69-7","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.12817"},{"key":"key-10.17116\/jnevro20171179263-69-8","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbiomolbio.2003.10.002"},{"key":"key-10.17116\/jnevro20171179263-69-9","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12865"},{"key":"key-10.17116\/jnevro20171179263-69-10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2011.03109.x"},{"key":"key-10.17116\/jnevro20171179263-69-11","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2012.02.035"},{"key":"key-10.17116\/jnevro20171179263-69-12","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2014.06.001"},{"key":"key-10.17116\/jnevro20171179263-69-13","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.114.212779"},{"key":"key-10.17116\/jnevro20171179263-69-14","unstructured":"Belousova ED. Efficacy and tolerability of perampanel as additional drug of teenagers with drugresistant partial epilepsy: results of a randomized doubleblind placebocontrolled study conducted in the Russian Federation. Epilepsiya i paroksizmal\u2019nye sostoyaniya. 2014;(1):27-33. (In Russ.)"},{"key":"key-10.17116\/jnevro20171179263-69-15","unstructured":"Vlasov PN. Efficacy and tolerability:results of a double-blind, placebo-controlled, and extended open study evaluating the long-term safety and efficacy perampanela in Russia. Epilepsiya i paroksizmal\u2019nye sostoyaniya. 2014;(1):16-17. (In Russ.)"},{"key":"key-10.17116\/jnevro20171179263-69-16","doi-asserted-by":"crossref","unstructured":"Karlov VA, Belyaev OV, Vlasov PN, Zhidkova IA, Volkov IV, Dmitrenko DV, Karas AYu, Kazennykh TV, Miguskina OI, Moskvicheva AV, Paramonova EN, Ponomareva IV, Chervyakov AV. Russian experience with perampanel in routine clinical practice. Nevrologiya, neiropsikhiatriya, psikhosomatika. 2016;(spetsvypusk 1):11-17. (In Russ.)","DOI":"10.14412\/2074-2711-2016-1S-11-17"},{"key":"key-10.17116\/jnevro20171179263-69-17","unstructured":"US Food and Drug Administration FDA. Clinical pharmacology review. Reference ID: 3205587 2012. The link is active on: 23.08.17. Available at: http:\/\/www.fda.gov\/downloads\/Drugs\/DevelopmentApprovalProcess\/DevelopmentResources\/UCM332052.pdf"},{"key":"key-10.17116\/jnevro20171179263-69-18","unstructured":"Laurenza A, Ferry J, Hussein Z. Population pharmacokinetics and pharmacodynamics of perampanel: a pooled analysis from three phase III trials. Poster presented at the 65th American Epilepsy Society (AES) Annual Meeting, Baltimore, MD, USA; December 2\u20146, 2011. Poster number P2.231."},{"key":"key-10.17116\/jnevro20171179263-69-19","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2015.1061504"},{"key":"key-10.17116\/jnevro20171179263-69-20","unstructured":"European Medicines Agency EMA, Fycompa SPC. Perampanel (Fycompa). Summary of product characteristics. Updated 13 November 2013. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/002434\/ WC500130815.pdf"},{"key":"key-10.17116\/jnevro20171179263-69-21","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12643"},{"key":"key-10.17116\/jnevro20171179263-69-22","unstructured":"Pylaeva OA, Mukhin KYu. Use of the new antiepileptic drug perampanel (Fycompa) in the treatment of epilepsy: a review of foreign literature. Russkii zhurnal detskoi nevrologii. 2014;3:36-42. (In Russ.)"},{"key":"key-10.17116\/jnevro20171179263-69-23","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2016.12.005"},{"key":"key-10.17116\/jnevro20171179263-69-24","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12558"},{"key":"key-10.17116\/jnevro20171179263-69-25","doi-asserted-by":"crossref","unstructured":"Mkrtchyan VR, Sergeev AM, Pochigaeva KI, Shpak IA. Budget impact analysis of perampanel for adjunctive treatment in epilepsy patients 12 years of age and older for partial onset seizures with or without secondary generalization and primary generalized tonic-clonic seizures in the Russian Federation. Farmakoekonomika. Sovremennaya farmakoekonomika i farmakoepidemiologiya. 2016;2:28-37. (In Russ.)","DOI":"10.17749\/2070-4909.2016.9.2.028-037"},{"key":"key-10.17116\/jnevro20171179263-69-26","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000001930"},{"key":"key-10.17116\/jnevro20171179263-69-27","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2017.05.036"},{"key":"key-10.17116\/jnevro20171179263-69-28","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12492"},{"key":"key-10.17116\/jnevro20171179263-69-29","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12212"},{"key":"key-10.17116\/jnevro20171179263-69-30","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-015-0285-4"},{"key":"key-10.17116\/jnevro20171179263-69-31","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13054"},{"key":"key-10.17116\/jnevro20171179263-69-32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2015.02.008"},{"key":"key-10.17116\/jnevro20171179263-69-33","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12529"},{"key":"key-10.17116\/jnevro20171179263-69-34","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-017-2245-z"},{"key":"key-10.17116\/jnevro20171179263-69-35","doi-asserted-by":"publisher","DOI":"10.4065\/82.1.40"},{"key":"key-10.17116\/jnevro20171179263-69-36","doi-asserted-by":"publisher","DOI":"10.2165\/11599780-000000000-00000"},{"key":"key-10.17116\/jnevro20171179263-69-37","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(12)61455-x"}],"container-title":["Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T12:40:03Z","timestamp":1570452003000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.mediasphera.ru\/issues\/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova-2\/2017\/9\/downloads\/ru\/1199772982017092063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017]]}},"alternative-id":["jnevro20171179263-69"],"URL":"https:\/\/doi.org\/10.17116\/jnevro20171179263-69","relation":{},"ISSN":["1997-7298"],"issn-type":[{"value":"1997-7298","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}